Skip to main content
OpenTrials
Completed

NCT Number: NCT01299259

Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease

The investigators hypothesize that text message reminders to girls diagnosed with pelvic inflammatory disease (PID) in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

The Children's Hospital of Philadelphia

Philadelphia, Pennsylvania, 19104, United States

About this study

The Centers for Disease Control (CDC) recommends that patients diagnosed with pelvic inflammatory disease (PID) receive follow-up care within 72 hours of diagnosis. However, recent studies show that the majority of teenage girls diagnosed with PID do not receive this follow-up care within 72 hours. We hypothesize that text message reminders to girls diagnosed with PID in the emergency department (ED) will improve follow-up to their primary care provider (PCP) after being discharged from the ED.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females aged 15 years and older
  • New diagnosis of PID, as defined by the 2006 CDC minimum criteria for diagnosis of PID, on current ED encounter
  • Determined by attending physician to be appropriate for outpatient treatment

Exclusion criteria

  • Patient does not have a cell phone that is capable of receiving text messages
  • Developmental disability
  • Non-English speaking
  • Pregnancy
  • Patient who was enrolled in this study on a prior ED visit

Treatment and study plan

Text message reminders

Behavioral

Patients in the intervention group will receive text messages on their cell phones following discharge from the emergency department reminding them to make an appointment with their primary care provider. Text messages will be sent daily for 4 days after discharge from the ED.

Primary outcomes

  1. PCP follow-up rates will be used to evaluate the efficacy of text message reminders.

    Time frame: PCP follow-up rates will be assessed 7-14 days after discharge from the ED.

Secondary outcomes

  1. Number of adolescents who accept text message reminders as an measure of feasibility and acceptability.

    Time frame: 7-14 days after discharge from the ED

    The acceptability among adolescents of using text message reminders after ED discharge in adolescents treated in a pediatric ED.

  2. Number of adolescents satisfied with ED care between the control group and intervention group as a measure of patient satisfaction.

    Time frame: 7-14 days after ED discharge

    Patient satisfaction of ED care when receiving text message reminders.

  3. Type of participant characteristics associated with PCP follow-up as a measure of behavior change, compliance and rate of follow-up care

    Time frame: 7-14 days after ED discharge

    Patient characteristics associated with PCP follow-up

  4. Barriers to PCP follow-up from an ED visit to measure use of text message technology and rate of change in follow-up care between groups

    Time frame: 7-14 days after ED visit

    Types of barriers encountered to PCP follow-up from an ED visit for PID care to measure rate of change in follow-up care between groups

Sponsors and collaborators

Lead sponsor

Children's Hospital of Philadelphia

Other

Registry information

Official study title

Improving Primary Care Follow-up for Adolescents With PID: A Randomized Controlled Trial Using Text Message Reminders

Important dates

Study start
2011
Primary completion
2014
Study completion
2014
First posted
Feb 18, 2011
Registry last updated
Oct 28, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.